<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04788498</url>
  </required_header>
  <id_info>
    <org_study_id>M D 34 / 2021</org_study_id>
    <nct_id>NCT04788498</nct_id>
  </id_info>
  <brief_title>Laparoscopic Single-site Surgery Versus Conventional Entry in Ovarian Cystectomy</brief_title>
  <official_title>Laparoendoscopic Single-site Surgery Versus Conventional Multi-port Laparoscopy in Presumed Benign Ovarian Cystectomy: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this work is to evaluate the postoperative consequences of laparoendoscopic single&#xD;
      site surgery relative to conventional laparoscopy in presumed benign ovarian cyst.&#xD;
&#xD;
      The hypothesis is that single incision technique might offer advantages over the standard&#xD;
      multi-port laparoscopy as potentially leading to less postoperative pain and improved&#xD;
      cosmoses from a relatively hidden umbilical scar, as well as risk reduction of postoperative&#xD;
      wound infection, hernia formation and elimination of multiple trocar site closure&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain</measure>
    <time_frame>at 24 hours ± 2 hour after the intervention</time_frame>
    <description>The pain will be assessed by a numeric rating scale of 0-10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>intraoperative</time_frame>
    <description>the time between the start of the incision up to the cutaneous closing of the trocar orifices</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the need for conversion to laparotomy</measure>
    <time_frame>intraoperative</time_frame>
    <description>the need for conversion to laparotomy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the need to add an additional trocar</measure>
    <time_frame>intraoperative</time_frame>
    <description>the need to add an additional trocar</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Ovarian Cyst Benign</condition>
  <arm_group>
    <arm_group_label>Laparoendoscpoic single site surgery LESS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>35 patients undergoing laparoscopic ovarian cystectomy A SILS Port (Covidien®) with three access inlets will be inserted into the abdominal cavity using a Heaney clamp</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional multiport laparoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>35 patients undergoing laparoscopic ovarian cystectomy It will be performed using a three-port system using a closed technique on the umbilicus, left and right lower quadrant area.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Laparoendoscpoic single site surgery LESS</intervention_name>
    <description>• A SILS Port (Covidien®) with three access inlets will be inserted into the abdominal cavity using a Heaney clamp</description>
    <arm_group_label>Laparoendoscpoic single site surgery LESS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Conventional multiport laparoscopy</intervention_name>
    <description>• It will be performed using a three-port system using a closed technique on the umbilicus, left and right lower quadrant area.</description>
    <arm_group_label>Conventional multiport laparoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The patients are aged 18 to 45 years with BMI &lt; 35 kg/m2 and that they exhibit a&#xD;
             surgical indication for a presumed benign ovarian pathology (PBOP) according to RCOG&#xD;
             Guideline no. 62. 2011:&#xD;
&#xD;
               -  simple ovarian cysts &gt;7cm and &lt;15cm.&#xD;
&#xD;
               -  Persistent simple cyst for more than 3 months.&#xD;
&#xD;
               -  Symptomatic patients with complicated cyst (e.g. hemorrhagic cyst, torsion, etc)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Previous midline laparotomies as suspected massive adhesions affecting&#xD;
             intraoperative maneuvers and time.&#xD;
&#xD;
               -  Chronic pelvic pain, endometriosis or pelvic inflammatory diseases will be&#xD;
                  excluded to avoid pelvic adhesions and bias in the quantification of&#xD;
                  postoperative pain.&#xD;
&#xD;
               -  Do not possess a native umbilicus giving difficult access to single port.&#xD;
&#xD;
               -  The 'risk of malignancy index' (RMI) should be used to exclude those women at&#xD;
                  greater risk of malignancy. Using an RMI cut-off of 200, a sensitivity of 70% and&#xD;
                  specificity of 90% can be achieved. if features suggestive of malignancy are&#xD;
                  encountered, a gynecological oncologist should be consulted regarding further&#xD;
                  evaluation and staging.&#xD;
&#xD;
               -  Benign teratomas for the difficulty of extraction after removal that affects the&#xD;
                  intraoperative maneuvers and time.&#xD;
&#xD;
               -  Contraindication to any laparoscopy like any medical condition worsened by&#xD;
                  pneumoperitoneum or the Trendelenburg position.&#xD;
&#xD;
               -  Contraindication to general anesthesia as all laparoscopic procedures are done&#xD;
                  under GA.&#xD;
&#xD;
               -  Contraindication to non-steroidal anti-inflammatories, paracetamol, or tramadol.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 5, 2021</study_first_submitted>
  <study_first_submitted_qc>March 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mahmoud Nabil</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ovarian Cysts</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

